LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: CoViD-19 e malattie croniche: conoscenze attuali, passi futuri e il progetto MaCroScopio.

    Martini, Nello / Piccinni, Carlo / Pedrini, Antonella / Maggioni, Aldo

    Recenti progressi in medicina

    2020  Volume 111, Issue 4, Page(s) 198–201

    Abstract: Chronicity and comorbidity influence the risk of CoViD-19 infection and the course of the disease ... among patients affected by CoViD-19 in the various countries and areas, but they consistently stress their impact ... on CoViD-19 infection. In order to protect chronic and frail patients, the Italian Medicines Agency has ...

    Title translation CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project.
    Abstract Chronicity and comorbidity influence the risk of CoViD-19 infection and the course of the disease. Epidemiological data and studies performed show different rates of chronic diseases and multimorbidity among patients affected by CoViD-19 in the various countries and areas, but they consistently stress their impact on CoViD-19 infection. In order to protect chronic and frail patients, the Italian Medicines Agency has taken measures to extend the therapeutic plans and monitoring registers; hopefully, therapeutic plans for antidiabetics, drugs for respiratory diseases and oral anticoagulant drugs will be abolished since they do not offer any additional advantage in terms of appropriateness and traceability of outcomes. The MaCroScopio project (Observatory on Chronic Diseases), regarding the CoViD-19 emergency, has started a new research path to foster the integration of the administrative data flows with the CoViD-19 Registers for planning and research purposes in the context of chronicity, as well as to evaluate the economic and organizational impact of the pandemic.
    MeSH term(s) Anticoagulants/therapeutic use ; Betacoronavirus ; COVID-19 ; Chronic Disease ; Comorbidity ; Coronavirus Infections/complications ; Coronavirus Infections/epidemiology ; Data Collection ; Health Knowledge, Attitudes, Practice ; Humans ; Hypoglycemic Agents/therapeutic use ; Pandemics ; Patient Care Planning ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Respiratory Tract Diseases ; Risk Factors ; SARS-CoV-2 ; Vulnerable Populations
    Chemical Substances Anticoagulants ; Hypoglycemic Agents
    Keywords covid19
    Language Italian
    Publishing date 2020-04-21
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 138266-4
    ISSN 2038-1840 ; 0034-1193
    ISSN (online) 2038-1840
    ISSN 0034-1193
    DOI 10.1701/3347.33180
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: CoViD-19 e malattie croniche: conoscenze attuali, passi futuri e il progetto MaCroScopio./ [CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project.]

    Martini, Nello / Piccinni, Carlo / Pedrini, Antonella / Maggioni, Aldo

    Recenti Prog Med

    Abstract: Chronicity and comorbidity influence the risk of CoViD-19 infection and the course of the disease ... among patients affected by CoViD-19 in the various countries and areas, but they consistently stress their impact ... on CoViD-19 infection. In order to protect chronic and frail patients, the Italian Medicines Agency has ...

    Abstract Chronicity and comorbidity influence the risk of CoViD-19 infection and the course of the disease. Epidemiological data and studies performed show different rates of chronic diseases and multimorbidity among patients affected by CoViD-19 in the various countries and areas, but they consistently stress their impact on CoViD-19 infection. In order to protect chronic and frail patients, the Italian Medicines Agency has taken measures to extend the therapeutic plans and monitoring registers; hopefully, therapeutic plans for antidiabetics, drugs for respiratory diseases and oral anticoagulant drugs will be abolished since they do not offer any additional advantage in terms of appropriateness and traceability of outcomes. The MaCroScopio project (Observatory on Chronic Diseases), regarding the CoViD-19 emergency, has started a new research path to foster the integration of the administrative data flows with the CoViD-19 Registers for planning and research purposes in the context of chronicity, as well as to evaluate the economic and organizational impact of the pandemic.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #32319439
    Database COVID19

    Kategorien

To top